IP Library Granted Patent US 8,632,883
Granted Patent B2
US 8,632,883 · App. 12/864,070 · Granted Jan 21, 2014

Separation media for biomolecules comprising porous hybrid particles containing inorganic metal oxide nanoparticles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,883
App. No.
12/864,070
Granted
Jan 21, 2014
Kind
B2
Abstract

The present invention relates to separation of biomolecules. More closely, the invention relates to a method for production of a separation medium comprising hybrid particles of inorganic and organic material as well as the hybrid particles produced by this method. Finally, the invention relates to use of the hybrid particles for separation of biomolecules, preferably phosphoproteins. The method comprises the following steps: addition of inorganic metal oxide particles to an organic solution to form a mixture; and emulsification of the mixture to form porous hybrid particles, wherein the density of the porous hybrid particles is between 1.0 and 1.5 g/ml, and wherein the inorganic particles have a shape and size that maximizes their active surface area enabling the inorganic particles to interact with biomolecules.

Claims (26)

1. A method for production of separation media for separation of biomolecules from a sample, comprising the following steps: addition of inorganic metal oxide particles selected from Group 4, 12, 13 and 14, to an organic solution to form a mixture; and emulsification of said mixture to form porous hybrid particles,

wherein each porous hybrid particle contains a plurality of inorganic metal oxide particles, and wherein the density of said porous hybrid particles is between 1.0 and 1.5g/ml, and wherein said inorganic particles have a shape and size that maximizes their active surface area accessible within the hybrid porous particles for interaction with biomolecules, wherein the inorganic metal oxide particles are less than 1000 nm in size.

2. The method of claim 1 , wherein the inorganic metal oxide particles are porous.

3. The method of claim 1 , wherein the inorganic metal oxide particles are less than 300 nm in size.

4. The method of claim 1 , wherein the inorganic metal oxide particles are selected from the group consisting of titania, zirconia, hafnia, alumina, zinkoxide, germania and tin dioxide.

5. The method of claim 1 , wherein the organic solution comprises polysaccharides.

6. The method of claim 5 , wherein the organic solution comprises agarose and said inorganic metal oxide particles comprise titania.

7. The method of claim 5 , wherein the polysaccharides are selected from the group consisting of agarose and dextran.

8. The method of claim 1 , wherein the organic solution comprises synthetic material.

9. The method of claim 8 , wherein the synthetic material is selected from the group consisting of (i) polystyrene/dvb and porogens, and (ii) methacrylates and porogens.

10. The method of claim 1 , wherein magnetic particles are incorporated into said organic solution.

11. The method of claim 1 , wherein the density of the porous hybrid particles is between 1.0 and 1.3 g/ml.

12. The method of claim 1 , wherein the inorganic metal oxide particles are selected from the group consisting of titania, zirconia and alumina.

13. The method of claim 1 , wherein the inorganic metal oxide particles are titania.

14. Porous hybrid particles comprising inorganic metal oxide particles selected from Group 4, 12, 13 and/or 14 which are incorporated in an organic solution to form porous hybrid particles, wherein each porous hybrid particle contains a plurality of inorganic metal oxide particles, wherein the density of the porous hybrid particles is between 1.0 and 1.5 g/ml, and wherein said inorganic particles have a shape and size that maximizes their active surface area accessible within the porous hybrid particles for interaction with biomolecules, wherein the inorganic metal oxide particles have a (volume-weighted, sphere volume-equivalent) average diameter less than 1000 nm.

15. The porous hybrid particles of claim 14 , wherein the inorganic metal oxide particles have a (volume-weighted, sphere volume-equivalent) average diameter less than 300 nm.

16. The porous hybrid particles of claim 14 , wherein the inorganic particles are selected from the group consisting of titania, zirconia, hafnia, alumina, zinc oxide, germania and tin dioxide.

17. The porous hybrid particles of claim 14 , wherein the organic solution is selected from polysaccharides or synthetic polymers.

18. The porous hybrid particles of claim 14 , wherein said inorganic particles comprise titania and the organic solution comprises agarose.

19. The porous hybrid particles of claim 14 , comprising a lid covering the hybrid particles, wherein said lid comprises up to 20% agarose.

20. The porous hybrid particles of claim 14 , wherein magnetic particles are incorporated into said organic solution.

21. The porous hybrid particles of claim 14 , wherein the size of the particles is 5-500 μm.

22. The porous hybrid particles of claim 14 , wherein the density of the porous hybrid particles is between 1.0 and 1.3 g/ml.

23. The porous hybrid particles of claim 14 , wherein the inorganic metal oxide particles are selected from the group consisting of titania, zirconia and alumina.

24. The porous hybrid particles of claim 14 , wherein the inorganic metal oxide particles are titania.

25. The porous hybrid particles of claim 14 , wherein the size of the particles is 25-100 μm.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2010
From: LARSSON, ANDERS; MEYER, ULRIKA; NORRMAN, NILS; OHMAN, JOHAN
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 024725/0978 →